Monday, December 23, 2024
HomeTagsODD

ODD

CTB001, Bioheng auto CAR – T Product, received Orphan Drug Designation (ODD) from the U.S. FDA

Recently, Nanjing Bioheng Biotech Co., Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell therapy product CTB001 received Orphan Drug Designation...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics